Sevenfold rise in likelihood of pertussis test requests in a stable set of australian general practice encounters, 2000-2011

Medical Journal of Australia

Volumn 198, Issue 11, 2013, Pages 624-628

  Kaczmarek, Marlena C ^a,b,c   Valenti, Lisa ^d   Kelly, Heath A ^c   Ware, Robert S ^a,b   Britt, Helena C ^d   Lambert, Stephen B ^a  

^a Queensland Children's Medical Research Institute   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; AWARENESS; CHILD; CORRELATION ANALYSIS; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFANT; LABORATORY TEST; MEDICAL INFORMATION; NATIONAL NOTIFIABLE DISEASES SURVEILLANCE SYSTEM; PERTUSSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SEASONAL VARIATION;

ADOLESCENT; ADULT; AGE FACTORS; AUSTRALIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE NOTIFICATION; GENERAL PRACTICE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; WHOOPING COUGH; YOUNG ADULT;

EID: 84879136027     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.10044     Document Type: Article

References (26)

1. Edwards K, Decker M. Pertussis vaccines. In: Plotkin S, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia: Elsevier, 2008: 467-517.
2. Heininger U. Pertussis: what the pediatric infectious disease specialist should know. Pediatr Infect Dis J 2012; 31: 78-79.
3. Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics 2011; 3: 183-188.
4. Fisman DN, Tang P, Hauck T, et al. Pertussis resurgence in Toronto, Canada: a populationbased study including test-incidence feedback modeling. BMC Public Health 2011; 11: 694.
5. Crespo I, Cardeñosa N, Godoy P, et al. Epidemiology of pertussis in a country with high vaccination coverage. Vaccine 2011; 29: 4244-4248.
6. Reid S, Wilson E. New Zealand pertussis epidemiology and the Global Pertussis Initiative immunisation strategies. N Z Med J 2011; 124: 63-64.
7. NNDSS Annual Report Writing Group. Australia's notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep 2012; 36: 1-69.
8. Jenkinson D. Increase in pertussis may be due to increased recognition and diagnosis. BMJ 2012; 345: e5463.
9. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ 2005; 172: 509-515.
10. Spokes PJ, Quinn HE, McAnulty JM. Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. N S W Public Health Bull 2010; 21: 167-173.
11. Britt H, Miller G, Charles J, et al. General practice activity in Australia 2009-10. Canberra: Australian Institute of Health and Welfare, 2011. (AIHW Cat. No. GEP 27; General Practice Series No. 27.) http://www.aihw.gov.au/publicationdetail/?id=6442472433 (accessed May 2013).
12. Wonca International Classification Committee. ICPC-2 - English: International Classification of Primary Care - 2nd Edition. Singapore: Wonca, 1998. http://www.kith.no/upload/2705/ICPC-2-English.pdf (accessed Dec 2008).
13. Australian Government Department of Health and Ageing. Australian national notifiable diseases case definitions. Pertussis case definition. http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndsscasedefs-cd_pertus.htm (accessed May 2012).
14. Centers for Disease Control and Prevention. Pertussis epidemic - Washington, 2012. MMWR Morb Mortal Wkly Rep 2012; 61: 517-522.
15. Cherry JD. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med 2012; 367: 785-787.
16. Guiso N, Wirsing von König CH, Forsyth K, et al. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine 2011; 29: 1115-1121.
17. Australian Government Department of Health and Ageing. MBS Online Medicare Benefits Schedule. http://www.health.gov.au/internet/mbsonline/publishing.nsf (accessed May 2013).
18. Australian Government Department of Health and Ageing. Review of Australia's health sector response to pandemic (H1N1) 2009: lessons identified. Canberra: Commonwealth of Australia, 2011. http://www.flupandemic.gov.au/internet/panflu/publishing.nsf/Content/review-2011/$File/lessons%20identified-oct11.pdf (accessed May 2013).
19. Bonacruz-Kazzi G, McIntyre P, Hanlon M, Menzies R. Diagnostic testing and discharge coding for whooping cough in a children's hospital. J Paediatr Child Health 2003; 39: 586-590.
20. Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11: 557-570.
21. Tartof SY, Lewis M, Kenyon C, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013; 131: e1047-e1052.
22. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 2012; 308: 454-456.
23. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012; 54: 1730-1735.
24. Vickers D, Ross AG, Mainar-Jaime RC, et al. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. CMAJ 2006; 175: 1213-1217.
25. Quinn HE, Mahajan D, Hueston L, et al. The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules. N S W Public Health Bull 2011; 22: 224-229.
26. Octavia S, Sintchenko V, Gilbert GL, et al. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J Infect Dis 2012; 205: 1220-1224.